Bullish Case: Helium's future-price density peaks at $10 with secondary mass toward $12.5–15, while the market PDF even assigns ~0.10 density to $15. Calls out-traded puts 57%, led by the Apr-27 12.50C, and a flat, low-churn week after +37% over 90 days reads as consolidation, not exhaustion. Cost cuts, buybacks, and the dividend could support a grind toward $11–13 if Q3 confirms margins; the dense short-horizon return band near 0–10% favors slow upside over a blow-off top.

Bearish Case: QUAD is up 54.9% year-over-year and 37.4% in 90 days with no catalyst disclosed in supplied data — an uncertain, momentum-stretched setup prone to mean reversion. Helium's AI signal is -1.09%, the term structure is backwardated (Sep 117%–250% IVs), and Apr-27 ATM put IV ~70% prices event risk into late-October earnings. The odds curves hold ~31% mass below $7.65, and SPY's surface keeps deep-strike IV near 35+ out 260 days, so macro shocks hit levered small caps hardest.

Potential Outcomes:

• 35%: $9.3–11.2 digestion (mode of both PDFs); falsified by <$9 or >$11.2 by Dec.
• 25%: $8–9.3 pullback via SPY-skew transmission; falsified holding >$9.5.
• 20%: $11–13 on buyback/margin follow-through.
• 15%: <$8 after a late-Oct Q3 miss.
• 5%: >$13 on M&A/catalyst.

Oracle: defined-risk spreads fit thin books (Apr-27 12.5C: .35/.105 wide) better than directional bets; watch $9.5/$11 triggers, Dec dividend, Oct/Dec Fed. My five prior forecasts sat below realized price — recalibrate humility upward.

September 15, 2026